Get the Stockscreener App
88.05
1.81%
-1.62
After Hours:
88.03
-0.02
-0.02%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc Stock (MRK) Latest News
Market Whales and Their Recent Bets on MRK Options - Benzinga
Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Buck Wealth Strategies LLC Has $8.90 Million Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma - Marketscreener.com
Merck: launch of a phase 3 study in lymphoma -February 06, 2025 at 08:24 am EST - Marketscreener.com
State of Alaska Department of Revenue Cuts Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
The Merck & Co., Inc. (NYSE:MRK) Annual Results Are Out And Analysts Have Published New Forecasts - Simply Wall St
Long Run Wealth Advisors LLC Has $3.66 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Inman Jager Wealth Management LLC Invests $1.37 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma - Business Wire
Financial Advisory Partners LLC Sells 2,875 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co Inc (MRK) Pharmaceutical Stock: Prospects & Analysis - INDODAX
Merck: Don't Fight The Tape, How Low Can It Go? (NYSE:MRK) - Seeking Alpha
Is Merck & Co. (MRK) the Best Dividend Stock to Buy and Hold? - Insider Monkey
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance - Benzinga
Merck & Co., Inc. (NYSE:MRK) Price Target Cut to $112.00 by Analysts at Bank of America - MarketBeat
BMO Capital Markets Issues Pessimistic Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Price Target Cut to $115.00 by Analysts at Citigroup - MarketBeat
Meritage Portfolio Management Increases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Choreo LLC Increases Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Tectonic Advisors LLC Buys 9,062 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q4 2024 Earnings Call Transcript - MSN
Why Merck & Co. Inc. (MRK) Went Down on Tuesday - Insider Monkey
Hager Investment Management Services LLC Invests $1.52 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Lockheed Martin Investment Management Co. Raises Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Stratos Investment Management LLC - MarketBeat
Paragon Capital Management Inc. Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Sargent Investment Group LLC Grows Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Yousif Capital Management LLC Cuts Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc.'s (NYSE:MRK) latest 6.9% decline adds to one-year losses, institutional investors may consider drastic measures - Yahoo Finance
1858 Wealth Management LLC Has $912,000 Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Cassia Capital Partners LLC Acquires 3,632 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Avitas Wealth Management LLC - MarketBeat
Merck & Co Inc (MRK) Shares Gap Down to $89.1 on Feb 4 - GuruFocus.com
Sylvest Advisors LLC Takes Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co Inc (MRK) Q4 2024 Earnings Call Highlights: Strong Growth in Oncology and Animal ... - Yahoo Finance
Symphony Financial Ltd. Co. Boosts Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
New Millennium Group LLC Sells 10,713 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Drops 2030 Sales Target For Gardasil As China Slump Continues - Citeline
Merck & Co., Inc. (NYSE:MRK) Updates FY25 Earnings Guidance - MarketBeat
Merck Earnings: Gardasil Weighs on 2025 Growth, but Firm Still Undervalued - Morningstar
Merck: Ideal Case Of Why I Love Option Collars (Upgrade To Buy) (NYSE:MRK) - Seeking Alpha
Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential - Fortune
Big Pharma, Bigger Bargain: Why Merck Stock Is Too Cheap To Ignore (Upgrade) (NYSE:MRK) - Seeking Alpha
Merck's Keytruda Dominance and a Strong Oncology Pipeline Help Support Merck's Wide Moat - Morningstar
Why Merck (MRK) Is Plunging Today - Yahoo Finance
Why Merck (MRK) Stock Is Falling Today - Yahoo Finance
Merck shares plunge on weak 2025 outlook, pause in Gardasil shipments to China - Proactive Investors Australia
Top Midday Stories: China Retaliates With Tariffs, Antitrust Probe of Google; Merck Shares Tumble on Downbeat Guidance - Marketscreener.com
Merck & Co., Inc. (NYSE:MRK) Updates FY 2025 Earnings Guidance - MarketBeat
Aplastic Anemia Global Clinical Trials Review 2024 | Now Available - GlobeNewswire Inc.
Merck Halts China Gardasil Shipments, Boosting Investor Concern - Bloomberg
MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth - AlphaStreet
Merck shares sink 11% after vaccine shipments to China halted - Financial Times
Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China - Yahoo Finance
Merck stops Gardasil shipments to China, hitting 2025 outlook; shares tumble - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Hits New 12-Month Low Following Weak Earnings - MarketBeat
Beach Investment Counsel Inc. PA Trims Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck beats estimates on Q4 earnings, stock slides on tepid 2025 guidance - Yahoo Finance
Merck Shares Tumble Following Mixed Q4 Results and Weak 2025 Guidance - The Africa Logistics
E. Ohman J or Asset Management AB Sells 32,837 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
James J. Burns & Company LLC Acquires Shares of 6,301 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Stock Down 8% On Weak Outlook, Q4 Results Miss Estimates - RTTNews
Merck & Co., Inc. (NYSE:MRK) Posts Quarterly Earnings Results, Misses Estimates By $0.13 EPS - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Releases Quarterly Earnings Results, Misses Estimates By $0.13 EPS - MarketBeat
Wall St set for subdued open after China's retaliatory tariffs -February 04, 2025 at 08:52 am EST - Marketscreener.com
Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook - Benzinga
Merck beats estimates on fourth-quarter on earnings—but stock slides pre-market on tepid 2025 guidance - Yahoo Finance
Merck & Co., Inc. Provides Earnings Guidance for the Full Year 2025 -February 04, 2025 at 06:30 am EST - Marketscreener.com
Flavin Financial Services Inc. Invests $1.66 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Compass Capital Management Inc. Acquires 22,838 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
2.58%
0.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):